These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4005436)

  • 1. [Phase II trial of mitoguazone in patients with recurrent extensive cervicofacial tumors].
    Coninx P; Nasca S; Jezekova D; Roelandt H; Morel M; Legros M; Cattan A
    Bull Cancer; 1985; 72(2):153-4. PubMed ID: 4005436
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
    Perry DJ; Crain SM; Weltz MD; Wilson JP; Davis RK; Woolley PV; Forastiere AA; Taylor HG; Weiss RB
    Cancer Treat Rep; 1983 Jan; 67(1):91-2. PubMed ID: 6616496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of mitoguazone in patients with advanced head and neck cancer.
    Thongprasert S; Bosl GJ; Geller NL; Wittes RE
    Cancer Treat Rep; 1984 Oct; 68(10):1301-2. PubMed ID: 6525604
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
    Luedke DW; Maddox W; Birch R; Velez-Garcia E; Schleuter J
    Cancer Treat Rep; 1986 Apr; 70(4):529-30. PubMed ID: 3698048
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
    Forastiere AA; Crain SM; Garbino C; Tipping SJ; Perry DJ; Kasdorf H; Van Echo DA
    Cancer Treat Rep; 1984 Apr; 68(4):687-8. PubMed ID: 6713424
    [No Abstract]   [Full Text] [Related]  

  • 6. Inefficacy of methylglyoxal bis(guanylhydrazone) (MGBG) in patients with recurrent head and neck squamous cell carcinoma.
    Arteaga CL; Clark GM
    Invest New Drugs; 1989 Jul; 7(2-3):281-3. PubMed ID: 2793385
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
    Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
    Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of amsacrine in metastatic or locally recurrent squamous cell carcinoma from head and neck primaries: a Southwest Oncology Group study.
    Witherspoon RP; Legha SS; Reimer RR; Talley RW; Stuckey WJ; Dixon DO; McCracken JD; Stephens RL; Oishi N
    Cancer Treat Rep; 1984 Feb; 68(2):435-6. PubMed ID: 6546532
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck.
    Dimery IW; Neidhart JA; McCarthy K; Krakoff IH; Hong WK
    Cancer Treat Rep; 1987 Apr; 71(4):425-6. PubMed ID: 3548960
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
    Kelsen D; Chapman R; Bains M; Heelan R; Dukeman M; Golbey R
    Cancer Treat Rep; 1982 Jun; 66(6):1427-9. PubMed ID: 7083245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of mitoguazone in patients with refractory germ cell tumors.
    Chun H; Bosl GJ
    Cancer Treat Rep; 1985 Apr; 69(4):461-2. PubMed ID: 2986835
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of mitogauzone in malignant primary brain tumors.
    Feun LG; Yung WK; Stewart DJ; Savaraj N; Bodey GP
    Cancer Treat Rep; 1985 Mar; 69(3):329-30. PubMed ID: 3978660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II evaluation of diaziquone in recurrent head and neck cancer.
    Kish JA; Ensley J; Al-Sarraf M
    Cancer Treat Rep; 1986 May; 70(5):671-2. PubMed ID: 3708616
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial.
    Ravry MJ; Omura GA; Hill GJ; Bartolucci AA; Velez-Garcia E
    Cancer Treat Rep; 1986 Apr; 70(4):533-4. PubMed ID: 3698050
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase I-II trial with cisplatin and 5-FU in recurrent head and neck cancer: an effective outpatient schedule.
    Merlano M; Tatarek R; Grimaldi A; Margarino G; Rosso R
    Cancer Treat Rep; 1985 Sep; 69(9):961-4. PubMed ID: 4040809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
    Benner SE; Lippman SM; Huber MH; Hong WK
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):22-5. PubMed ID: 7481857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of methylglyoxal-bis-(guanylhydrazone) in non-small-cell lung cancer.
    Chapman R; Kelsen D; Gralla R; Itri L; Casper E; Young C; Golbey R
    Cancer Clin Trials; 1981; 4(4):389-91. PubMed ID: 6274532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoguazone in advanced renal carcinoma: a phase II trial of the Southwest Oncology Group.
    Knight WA; Drelichman A; Fabian C; Bukowski RM
    Cancer Treat Rep; 1983 Dec; 67(12):1139-40. PubMed ID: 6652631
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intra-arterial chemotherapy of head and neck tumors: statistical study of 129 cases treated at the Institut Gustave Roussy].
    Richard JM; Sancho H
    Biomedicine; 1973 Sep; 18(5):429-35. PubMed ID: 4127613
    [No Abstract]   [Full Text] [Related]  

  • 20. Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).
    Galetta D; Giotta F; Rosati G; Gebbia V; Manzione L; Di Bisceglie M; Borsellino N; Colucci G
    Anticancer Res; 2005; 25(6C):4445-9. PubMed ID: 16334124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.